The research focus is on the immune response against the Epstein-Barr virus (EBV), and EBV-associated disease. With a better understanding of how immunity against EBV is established, the group seeks to establish predictive markers for the development and novel strategies for the treatment of virus-associated disorders.
(Description adapted from working group website: see link above)